188 related articles for article (PubMed ID: 25695660)
21. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
Haga S; Tsuchiya H; Hirai T; Hamano T; Mimori A; Ishizaka Y
Exp Lung Res; 2015 Feb; 41(1):21-31. PubMed ID: 25275723
[TBL] [Abstract][Full Text] [Related]
22. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.
Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T
Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386
[TBL] [Abstract][Full Text] [Related]
23. Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
Kishi K; Jin D; Takai S; Muramatsu M; Katayama H; Tamai H; Miyazaki M
Pediatr Res; 2006 Jul; 60(1):77-82. PubMed ID: 16690960
[TBL] [Abstract][Full Text] [Related]
24. Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease.
Todorovich-Hunter L; Dodo H; Ye C; McCready L; Keeley FW; Rabinovitch M
Am Rev Respir Dis; 1992 Jul; 146(1):213-23. PubMed ID: 1626806
[TBL] [Abstract][Full Text] [Related]
25. Effects of everolimus in combination with sildenafil in monocrotaline-induced pulmonary hypertension in rats.
Ilgin S; Burukoglu D; Atli O; Sirmagul B
Cardiovasc Toxicol; 2012 Mar; 12(1):46-55. PubMed ID: 21811847
[TBL] [Abstract][Full Text] [Related]
26. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
[TBL] [Abstract][Full Text] [Related]
27. Right ventricle-sparing heart transplantation effective against iatrogenic pulmonary hypertension.
Lovoulos C; Tittle S; Goldstein L; Austin DJ; Singh S; Rocco E; Keane J; Tang P; Kopf GS; Elefteriades JA
J Heart Lung Transplant; 2004 Feb; 23(2):236-41. PubMed ID: 14761772
[TBL] [Abstract][Full Text] [Related]
28. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2004 Aug; 496(1-3):129-39. PubMed ID: 15288584
[TBL] [Abstract][Full Text] [Related]
29. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.
Todorovich-Hunter L; Johnson DJ; Ranger P; Keeley FW; Rabinovitch M
Lab Invest; 1988 Feb; 58(2):184-95. PubMed ID: 3123799
[TBL] [Abstract][Full Text] [Related]
30. Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats.
Ahmed LA; Obaid AA; Zaki HF; Agha AM
Eur J Pharmacol; 2014 Oct; 740():379-87. PubMed ID: 25062790
[TBL] [Abstract][Full Text] [Related]
31. Correction: Adult Cardiac Expression of the Activating Transcription Factor 3, ATF3, Promotes Ventricular Hypertrophy.
Koren L; Elhanani O; Kehat I; Hai T; Aronheim A
PLoS One; 2013; 8(9):. PubMed ID: 29294481
[TBL] [Abstract][Full Text] [Related]
32. Correction: Pre-Treatment with Amifostine Protects against Cyclophosphamide-Induced Disruption of Taste in Mice.
Mukherjee N; Carroll BL; Spees JL; Delay ER
PLoS One; 2013; 8(7):. PubMed ID: 29220848
[TBL] [Abstract][Full Text] [Related]
33. Correction: Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells.
PLOS ONE Staff
PLoS One; 2016; 11(5):e0155281. PubMed ID: 27145125
[TBL] [Abstract][Full Text] [Related]
34. Correction: p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway Inflammation.
Mothes B; Bucher K; Ammon-Treiber S; Schwab M; Piekorz RP; Hirsch E; Nürnberg B; Beer-Hammer S
PLoS One; 2016; 11(9):e0163577. PubMed ID: 27644040
[TBL] [Abstract][Full Text] [Related]
35. Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension.
López-Meseguer M; Quezada CA; Ramon MA; Lázaro M; Dos L; Lara A; López R; Blanco I; Escribano P; Roman A;
PLoS One; 2018; 13(1):e0192100. PubMed ID: 29377947
[TBL] [Abstract][Full Text] [Related]
36. Correction: Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.
Wang B; Yang Q; Bai WW; Xing YF; Lu XT; Sun YY; Zhao YX
PLoS One; 2019; 14(8):e0220845. PubMed ID: 31369643
[TBL] [Abstract][Full Text] [Related]
37. Correction: Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart through the Deacetylation of LCAD.
Chen T; Liu J; Li N; Wang S; Liu H; Li J; Zhang Y; Bu P
PLoS One; 2016; 11(5):e0155173. PubMed ID: 27144309
[TBL] [Abstract][Full Text] [Related]
38. Correction: Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy.
PLOS ONE Staff
PLoS One; 2018; 13(4):e0194260. PubMed ID: 29630624
[TBL] [Abstract][Full Text] [Related]
39. Correction: Cystathionine-Gamma-Lyase Gene Deletion Protects Mice against Inflammation and Liver Sieve Injury following Polymicrobial Sepsis.
Gaddam RR; Fraser R; Badiei A; Chambers S; Cogger VC; Le Couteur DG; Ishii I; Bhatia M
PLoS One; 2017; 12(8):e0183304. PubMed ID: 28797076
[TBL] [Abstract][Full Text] [Related]
40. Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer.
Guo Z; Wang X; Cheng D; Xia Z; Luan M; Zhang S
PLoS One; 2017; 12(10):e0186965. PubMed ID: 29045495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
